Issue link: https://beckershealthcare.uberflip.com/i/1398595
52 Executive Briefing Automation naturally supports standardization and policy compliance by minimizing human factors. A study from endoscopy found adherence to reprocessing guidelines increased from 1.4% to 75.4% with increasing automation of the steps. Staff were happier, with physical discomfort diminishing with automation. 20 In ultrasound, manual disinfection methods can also be prone to human error, as the user needs to verify and record the critical parameters are met each time on all surfaces of the probe. In the survey, 91% of respondents preferred to use automated processes for probe reprocessing. 17 trophon®2: leader in automated ultrasound probe HLD Nanosonics trophon® is the global standard of care in ultrasound probe HLD helping protect patients from the risk of cross contamination. The trophon family includes trophon® EPR and trophon®2 which share the same core technology of sonically activated hydrogen peroxide. trophon is bactericidal, fungicidal, virucidal and mycobactericidal. Every day, 80,000 patients are protected from cross contamination risk because the ultrasound probe used in their procedure has undergone HLD with trophon. Over 22,000 units are used across North America, in over 5,000 hospitals and clinics including all luminary hospitals. trophon is designed with point of care placement in mind to support staff and patient safety, throughput and cost effectiveness. trophon uses a proprietary hydrogen peroxide disinfectant that is sonically activated to create a mist in the probe chamber, penetrating crevices, grooves and imperfections on the probe body and handle. trophon is a closed, automated HLD device and mitigates the risk of exposure to hazardous chemicals often associated with manual methods. The trophon HLD process is standardized in every department. The critical parameters are automatically controlled and validated by the device, further verified with a chemical indicator each cycle. trophon efficacy has been demonstrated in peer review with microbiological studies and in clinical settings. 1,21-24 Nanosonics' second generation device, trophon2, launched in 2018 and is enabled with AcuTrace® RFID technology to deliver digitized capture of the reprocessing record. Nanosonics AuditPro TM : Your key to infection prevention standardization The new Nanosonics AuditPro provides facilities with the opportunity to improve and standardize ultrasound infection control compliance across all ultrasound procedures, supporting the management of organizational and facility risk and patient care. Nanosonics AuditPro comprises a mobile scanning device (MSD) for ultrasound users coupled with sophisticated software to manage compliance. The MSD uniquely sits with the ultrasound console at point of care enabling users to incorporate infection control considerations as part of everyday practice. With built in education as part of the workflow, users qualify every procedure against the Spaulding classification for probe disinfection requirements, standardizing the infection prevention decision every time. The software combines ultrasound patient procedures and probe disinfection information, including HLD records from the trophon2 device, and interrogates data captured through the clinical workflow to create non-compliance notifications and intuitive information rich dashboards. Together, trophon2 and AuditPro mitigate risk to patients and healthcare facilities, arming healthcare staff, IPs and risk and quality managers with tools to drive compliance. Discover how Nanosonics AuditPro can standardize your ultrasound infection prevention practices, help you meet accreditation requirements and deliver best practice patient care across your organization. n Nanosonics is an Australian infection prevention company that has successfully developed and commercialized a unique automated disinfection technology, trophon®. Since 2009, trophon EPR and trophon2 have redefined the standard of care in ultrasound probe reprocessing providing fail-safe ultrasound probe high level disinfection (HLD) to protect patients from the risk of cross contamination. Nanosonics is proud to introduce Nanosonics AuditPro™. Nanosonics AuditPro provides facilities and their broader organizations a digital workflow compliance management system by tracking ultrasound procedures across all departments to ensure probes have been appropriately disinfected according to the Spaulding classification. To learn more, visit https://www.nanosonics.us/ "With the growing trend toward stricter reprocessing guidelines, manual HLD is not the best approach. Technology such as trophon is providing us with a safer way to disinfect transducers at point of care." Sylvia Ford, MS, RN, CIC, Infection Prevention Nurse 2, The University of Kansas Health System "We looked to implement Nanosonics AuditPro to automate the linking of reprocessing of ultrasound probes to patient procedures. However, by far the most beneficial part has been the workflow education built into the system...the system guides them to make the right decision, it challenges how we can learn from it...This ensures we are a high reliability organization making sure our patients are always protected." Lindsay Turner, RT(R), (M), RDMS(AB)(OB/GYN), RVT, Lead Sonographer, Imaging Services Hutchison Regional Medical Center References: 1. Buescher DL et al. 2016. Ultrasound Obstet Gynecol 47(5): 646-651. 2. Oide S et al. 2019. J Med Ultrason 46(4): 475-479. 3. Keys M et al. 2015. Crit Care Resusc 17(1): 43-46. 4. Leroy S, et al. J Hosp Infect 2013;83(2): 99-106. 5. M'Zali, F., et al. 2014. PLoS One 9(4): e93368. 6. Spaulding EH 1968. Chemical disinfection of medical and surgical materials. Disinfection, sterilization, and preservation. Lawrence C, Block SS. Philadelphia, Lea & Febiger: 517-531. 7. CDC 2008. Guideline for Disinfection and Sterilization in Healthcare Facilities 8. FDA 2019. Marketing Clearance of Diagnostic Ultrasound Systems and Transducers. 9. 21 CFR 880.6885 Rev April 2020. Liquid chemical sterilants/high level disinfectants. 10. FDA 2000. Content and Format of Premarket Notification 510(k) Submissions for Liquid Chemical Sterilants/ HLDs. 11. MOU 225-93-4005. Memorandum of Understanding Between US FDA Public Health Service, Dept of Health and Human Services, US EPA. 12. ANSI/AAMI ST58:2013 Chemical sterilization and HLD in health care facilities. 13. Scott D et al. 2018. Ultrasound 26(3): 168-177. 14. HPS, HFS 2016. NHS Scotland Guidance for Decontamination of Semi-Critical Ultrasound Probes 15. Gery A et al. 2021. J Hosp Infect 111: 184-188. 16. Buetti N et al. 2020. Clin Infect Dis. 2020. doi: 10.1093/cid/ ciaa1817. 17. Carrico RM et al. 2018. Am J Infect Control 46(8): 913-920. 18. AORN 2018. HLD. AORN Guidelines for perioperative practice. 19. TJC 2017. Improperly sterilized or HLD equipment – a growing problem. Quick Safety: 1-3. 20. Ofstead CL et al. 2010. Gastroenterol Nurs 33(4): 304-311. 21. Vickery K et al. 2014. J Infect Public Health. 7(2):153-60. 22. Becker B et al. 2017. GMS Hygiene and Infection Control 12: Doc02. 23. Ryndock E et al. 2016. J Med Virol. 88(6):1076-80. 24. Ngu A et al. 2015. Infect Control Hosp Epidemiol. 2015;36(5):1-4.